SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sepracor-Looks very promising
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
10280 115 0 SEPR
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
7955I could have sworn that at one of these recent presentations they talked about aBiomaven-1/17/2005
7954No registration required.... Bold move with 75% price premium! January 17, 20rkrw-1/17/2005
7953latimes.com Tried to post this link from front page of today's la times heaewolf-1/17/2005
7952<i>than what’s already available in terms of efficacy</i> And what Biomaven-1/17/2005
7951>> Gratuitous close: Who knows what the level of anti-pharma and anti-mediscaram(o)uche-1/17/2005
7950I agree, and have had some for quite some time (too long it would now appear) anquidditch-1/17/2005
7949I do believe Lunesta will do $1 B. That being said, I am beginning to think IndRobohogs-1/17/2005
7948Dew: <I have my doubts that Lunesta will shine in the chronic segment of the quidditch-1/17/2005
7947For the transient insomnia market, detailing matters. For the <i>chronic&lDewDiligence_on_SI-1/17/2005
7946<i>if they are large</i> Well that they were significant at all wasBiomaven-1/15/2005
7945i agree. this point seems especially important: "After removing insomnia-tom r. phillips-1/15/2005
7944for those interested in further detail re. Acadia deal.... Message 20951623scaram(o)uche-1/14/2005
7943Free Trial Offer I saw this offer on a cable TV channel for the first time - heDoc Bones-1/13/2005
7942Normally it's two approved drugs one or both of which is already off-patent Biomaven-1/12/2005
7941<i>In any event the FDA hates combination drugs</i> Is there anythiSidney Street-1/12/2005
7940<i>They'd be nuts.</i> Agreed. In any event the FDA hates comBiomaven-1/12/2005
7939<<Is it totally wacky to wonder whether they are considering a resurrectiorkrw-1/12/2005
7938I was thinking about why they did a trial with Prozac, rather than an SSRI with John Metcalf-1/12/2005
7937<i> I wonder why SEPR didn't include the p factor?</i> Because Biomaven-1/12/2005
7936From the pr: <<In this study, eszopiclone co-administered with fluoxetine quidditch-1/12/2005
7935<i>door-opener for Sepracor when they are establishing their product</iBiomaven-1/12/2005
7934Pfizer and Neurocrine will have time to run their own complementary study, if thIcebrg-1/12/2005
7933Considering that something like half the market is depression-based and other drRobohogs-1/12/2005
7932The Lunesta launch delay wasn't the tidbit they were saving for the JP MorgaSidney Street-1/12/2005
7931This is absolutely huge! JonRobohogs-1/12/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News